Molbio Diagnostics IPO to open on August 10 with Rs 768-807 price band
Key Takeaways
- •Molbio Diagnostics plans to launch its IPO on August 10, 2026.
- •The price band for the issue has been fixed at Rs 768 to Rs 807 per share.
- •The public issue is valued at Rs 939.70 crore, including a fresh issue of Rs 200 crore and an offer for sale of Rs 739.70 crore.
- •The company intends to use the proceeds to expand R&D infrastructure, strengthen manufacturing capabilities, and support its diagnostics portfolio.
Molbio Diagnostics is set to launch its initial public offering on August 10, 2026, with a price band of Rs 768 to Rs 807 per share.
The public issue is valued at Rs 939.70 crore and includes a fresh issue of Rs 200 crore along with an offer for sale (OFS) of Rs 739.70 crore by existing shareholders.
The molecular diagnostics company said it plans to use the proceeds to expand its research and development infrastructure, strengthen manufacturing capabilities, and support its healthcare diagnostics portfolio.
For investors tracking primary market activity, the mix of a fresh issue and OFS means the IPO is designed both to raise capital for the company and to provide an exit route for some existing shareholders, a structure commonly used when companies seek funding for growth while also broadening ownership.
Molbio Diagnostics IPO opens August 10; company targets Rs 940 crore through public issue
